Detalhe da pesquisa
1.
Potential for Maternally Administered Vaccine for Infant Group B Streptococcus.
N Engl J Med
; 389(3): 215-227, 2023 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37467497
2.
Prefusion F Protein-Based Respiratory Syncytial Virus Immunization in Pregnancy.
N Engl J Med
; 386(17): 1615-1626, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35476650
3.
Respiratory Syncytial Virus Prefusion F Vaccination: Antibody Persistence and Revaccination.
J Infect Dis
; 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38606958
4.
Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine.
J Infect Dis
; 225(12): 2056-2066, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34931667
5.
A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine.
J Infect Dis
; 225(8): 1357-1366, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34932102
6.
Immune clearance of attenuated rabies virus results in neuronal survival with altered gene expression.
PLoS Pathog
; 8(10): e1002971, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23071441
7.
Association between anti-capsular IgG levels at birth and risk of invasive group B streptococcus disease in Finnish newborns: a retrospective case-control study.
Lancet Microbe
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38679040
8.
Characterization of a single-cycle rabies virus-based vaccine vector.
J Virol
; 84(6): 2820-31, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20053743
9.
Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses.
PLoS One
; 8(6): e67123, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23840600
10.
Rabies virus as a research tool and viral vaccine vector.
Adv Virus Res
; 79: 139-64, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21601047
11.
Dendritic cells infected by recombinant rabies virus vaccine vector expressing HIV-1 Gag are immunogenic even in the presence of vector-specific immunity.
Vaccine
; 29(1): 130-40, 2010 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-20728525